Showing results (71-80 of 505) with videos related to

Sort By:
Pageof 51
Scientific Reports|April 5, 2016
Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishieldsGoodwin G Jinesh, Rikiya Taoka, Qiang Zhang, et al.
Future Oncology (London, England)|April 4, 2019
Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record studyKyle Flannery, Marley Boyd, Jenny Black-Shinn, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 12, 2017
CF3DODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency programRikiya Taoka, Goodwin G Jinesh, Wenrui Xue, et al.
European Urology Oncology|June 2, 2020
Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of ShortageNathan Brooks, Supriya Nagaraju, Justin Matulay, et al.
Urologic Oncology|June 23, 2021
Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancerStephen B Williams, Meghan B Gavaghan, Anthony Fernandez, et al.
Urologic Oncology|February 4, 2018
Contribution of bladder cancer pathology assessment in planning clinical trialsCharles C Guo, Hikmat A Al-Ahmadie, Thomas W Flaig, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New AnalysisAshish M Kamat, Michael Cookson, J Alfred Witjes, et al.
The Journal of Urology|September 6, 2006
Vitamins C and K3 sensitize human urothelial tumors to gemcitabineWassim Kassouf, Ralph Highshaw, Gina M Nelkin, et al.
Oncology Reports|September 2, 2015
Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cellsHisashi Takeuchi, Chinedu O Mmeje, Goodwin G Jinesh, et al.
Urologic Oncology|December 11, 2012
Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meetingAndrea B Apolo, Herbert Barton Grossman, Dean Bajorin, et al.
Pageof 51